X-LINKED RETINOSCHISIS
Clinical trials for X-LINKED RETINOSCHISIS explained in plain language.
Never miss a new study
Get alerted when new X-LINKED RETINOSCHISIS trials appear
Sign up with your email to follow new studies for X-LINKED RETINOSCHISIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial offers hope for boys and men with rare blinding eye condition
Disease control Recruiting nowThis study tests a gene therapy called ATSN-201 for people with X-linked retinoschisis, a rare inherited eye disease that splits the retina and can lead to vision loss. The trial includes males aged 6 and older, and aims to see if the treatment is safe and can improve vision. The…
Matched conditions: X-LINKED RETINOSCHISIS
Phase: PHASE3 • Sponsor: Atsena Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
New study aims to sharpen vision tests for the blind
Knowledge-focused Recruiting nowThis study is for people with severe vision loss from diseases like retinitis pigmentosa or Stargardt disease. The goal is to find out which vision tests work best for people with very low vision, so future treatments can be measured more accurately. About 25 participants will tr…
Matched conditions: X-LINKED RETINOSCHISIS
Sponsor: Ray Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC